Back to User profile » Dr Timothy G Murray
Papers published by Dr Timothy G Murray:
Brolucizumab: Evaluation of Compassionate Use of a Complex Anti-VEGF Therapy
Murray JE, Gold AS, Latiff A, Murray TG
Clinical Ophthalmology 2021, 15:4731-4738
Published Date: 18 December 2021
Impact of the COVID-19 Pandemic on Essential Vitreoretinal Care with Three Epicenters in the United States
El Hamichi S, Gold A, Heier J, Kiss S, Murray TG
Clinical Ophthalmology 2020, 14:2593-2598
Published Date: 4 September 2020
Disaster Preparedness Impact In A Complex Ophthalmology Practice: A Review Of Patients Receiving Intravitreal Injections
El Hamichi S, Gold AS, Kon Graversen V, Latiff A, Murray TG
Clinical Ophthalmology 2019, 13:1999-2002
Published Date: 11 October 2019
Prevalence of refractive errors in children with retinoblastoma
Villegas VM, Wu SC, Murray TG, Cavuoto KM, Capo H, McKeown CA
Clinical Ophthalmology 2019, 13:431-435
Published Date: 25 February 2019
Treatment of vascular activity secondary to atypical choroidal nevus using intravitreal bevacizumab
Cavalcante ML, Villegas VM, Gold AS, Cavalcante LL, Lonngi M, Shah NV, Murray TG
Clinical Ophthalmology 2014, 8:1377-1382
Published Date: 22 July 2014
Advanced Coats’ disease treated with intravitreal bevacizumab combined with laser vascular ablation
Villegas VM, Gold AS, Berrocal AM, Murray TG
Clinical Ophthalmology 2014, 8:973-976
Published Date: 16 May 2014
Letter to the editor: immediate implications of improved surgical efficiency
Gologorsky D, Murray TG
Clinical Ophthalmology 2013, 7:2287-2288
Published Date: 6 December 2013
Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma
Shah NV, Houston SK, Markoe A, Murray TG
Clinical Ophthalmology 2013, 7:1877-1882
Published Date: 20 September 2013
Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma
Lonngi M, Houston SK, Murray TG, Sisk RA, Decatur CL, Cavalcante M, Markoe AM
Clinical Ophthalmology 2013, 7:427-435
Published Date: 27 February 2013
Transition to a novel advanced integrated vitrectomy platform: comparison of the surgical impact of moving from the Accurus vitrectomy platform to the Constellation Vision System for microincisional vitrectomy surgery
Murray TG, Layton AJ, Tong KB, Gittelman M, Latiff A, Gologorsky D, Vigoda MM
Clinical Ophthalmology 2013, 7:367-377
Published Date: 19 February 2013
Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment
Houston SK, Shah NV, Decatur C, Lonngi M, Feuer W, Markoe AM, Murray TG
Clinical Ophthalmology 2013, 7:193-198
Published Date: 22 January 2013
Clinical manifestations of optic pit maculopathy as demonstrated by spectral domain optical coherence tomography
Tzu JH, Flynn Jr HW, Berrocal AM, Smiddy WE, Murray TG, Fisher YL
Clinical Ophthalmology 2013, 7:167-172
Published Date: 18 January 2013
Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity
Shah NV, Houston SK, Markoe AM, Feuer W, Murray TG
Clinical Ophthalmology 2012, 6:1739-1748
Published Date: 29 October 2012
Retinoblastoma treatment burden and economic cost: impact of age at diagnosis and selection of primary therapy
Aziz HA, LaSenna CE, Vigoda M, Fernandes C, Feuer W, Aziz-Sultan MA, Murray TG
Clinical Ophthalmology 2012, 6:1601-1606
Published Date: 4 October 2012
Intraoperative intravitreal triamcinolone decreases macular edema after vitrectomy with phacoemulsification
Parke III DW, Sisk RA, Murray TG
Clinical Ophthalmology 2012, 6:1347-1353
Published Date: 17 August 2012
Ocular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification
Parke III DW, Sisk RA, Houston SK, Murray TG
Clinical Ophthalmology 2012, 6:925-931
Published Date: 18 June 2012
Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LHBETATAG retinal tumors
Piña Y, Houston SK, Murray TG, Koru-Sengul T, Decatur C, Scott WK, Nathanson L, Clarke J, Lampidis TJ
Clinical Ophthalmology 2012, 6:817-830
Published Date: 29 May 2012
Intraocular infections in the neonatal intensive care unit
Aziz HA, Berrocal AM, Sisk RA, Hartley K, Diaz-Barbosa M, Johnson RA, Hess D, Dubovy SR, Murray TG, Flynn Jr HW
Clinical Ophthalmology 2012, 6:733-737
Published Date: 14 May 2012
Evaluation of the surgical learning curve for I-125 episcleral plaque placement for the treatment of posterior uveal melanoma: a two decade review
Shah NV, Houston SK, Murray TG, Markoe AM
Clinical Ophthalmology 2012, 6:447-452
Published Date: 20 March 2012
Evaluation of economic efficiencies in clinical retina practice: activity-based cost analysis and modeling to determine impacts of changes in patient management
Murray TG, Tornambe P, Dugel P, Tong KB
Clinical Ophthalmology 2011, 5:913-925
Published Date: 12 July 2011
Can children undergoing ophthalmologic examinations under anesthesia be safely anesthetized without using an IV line?
Vigoda M, Latiff A, Murray T, Tutiven J, Berrocal A, Gayer S
Clinical Ophthalmology 2011, 5:503-508
Published Date: 20 April 2011
Clinical imaging and high-resolution ultrasonography in melanocytoma management
Daniel Gologorsky, Amy C Schefler, Fiona J Ehlies, et al
Clinical Ophthalmology 2010, 4:855-859
Published Date: 28 July 2010
Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration
R Prince Davis, Amy C Schefler, Timothy G Murray
Clinical Ophthalmology 2010, 4:703-707
Published Date: 28 June 2010